Amble Tirzepatide is a novel peptide compound with triple agonist activity targeting glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). This innovative peptide demonstrates significant potential for metabolic disorder research.
The compound appears as white lyophilized powder with molecular weight of 4731.33 and molecular formula C221H342N46O68. Our Amble Tirzepatide is produced under strict GMP conditions ensuring consistent high quality for research applications.
Research applications include:
Storage conditions require maintaining the product at or below -20°C in lyophilized form. For research use only, not intended for human consumption.